SecBot SecBot
8-K ·Filed Jun 29, 2026

ESTA

ESTABLISHMENT LABS HOLDINGS INC.
NEUTRAL
Impact 2/10
Horizonweeks Processed4mo ago SEC0001628280-26-045885
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

Monitor for any strategic shifts or M&A activity given Mr. Harris's background in value creation and M&A execution. No immediate catalyst; the appointment is routine and non-material.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
ESTA ▼ -19.65% at T+60d
NEUTRAL call -19.65% · α vs SPY -24.04% · entry $87.42 → $70.24
Entry = T+0 close
Jun 29, 2026
via day close
T+1d
-1.84%
call -1.84% · α -2.62%
$85.81
settled 4mo ago
T+5d
+4.74%
call +4.74% · α +3.35%
$91.56
settled 4mo ago
T+20d
+5.61%
call +5.61% · α +5.88%
$92.32
settled 3mo ago
T+60d
-19.65%
call -19.65% · α -24.04%
$70.24
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Establishment Labs appointed Taylor Harris to its Board of Directors, effective June 24, 2026. Mr. Harris brings extensive medtech and corporate finance experience, including former CEO of Cutera and CFO roles at MyoKardia, Zeltiq, and Thoratec. This is a routine board addition with no immediate financial or operational impact.

Key Facts

  • Taylor Harris appointed to the Board effective June 24, 2026, to serve until the 2027 annual meeting.
  • Mr. Harris will serve on the Audit Committee and the Nominating and Corporate Governance Committee.
  • Standard non-employee director compensation applies: initial equity grant of $170,000 and annual grant of $170,000.
  • Mr. Harris has over 25 years of experience in healthcare, medtech, and life sciences, including CEO of Cutera and CFO of MyoKardia (acquired by BMS for $13.1B).

Financial Impact

No financial impact from this board appointment.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
87% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-045885
Document: esta8k62926-ex991bod.htm0001628280-26-045885
Document: 0001628280-26-045885-index-headers.html0001628280-26-045885
Document: 0001628280-26-045885-index.html0001628280-26-045885
Document: 0001628280-26-045885.txt0001628280-26-045885
8 reports for ESTA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ESTA — sortable, filterable
TypeNow
Oct 15, 2026
12d ago
8-K
NEUTRAL ★ 3/10
$61.36awaiting T+60—$67.04 (+9.26%)
Aug 6, 2026
11w ago
8-K
MIXED ★ 6/10
$79.05awaiting T+60—$67.04 (−15.19%)
Jun 29, 2026
17w ago
3
NEUTRAL ★ 1/10
$85.81 $67.76▼ −21.03%▼ −23.85%$67.04 (−21.87%)
Jun 29, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$87.42 $70.24▼ −19.65%▼ −24.04%$67.04 (−23.31%)
May 6, 2026
24w ago
8-K
BULLISH ★ 8/10
$74.54 $92.54▲ +24.15%▲ +22.09%$67.04 (−10.06%)
May 6, 2026
24w ago
Insider Cluster
BEARISH ★ 6/10
$74.54 $92.54▼ −24.15%▼ −22.09%$67.04 (+10.06%)
Apr 24, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$65.47 $93.87▲ +43.38%▲ +38.60%$67.04 (+2.40%)
Apr 10, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$62.92 $87.99▲ +39.84%▲ +30.92%$67.04 (+6.55%)
Showing 8 of 8

US Market Status

Market Open — Closes in 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 29, 2026